AK
About
Dr. Anja König is a Managing Director in Basel, Switzerland.She is active in Switzerland and Europe and also responsible for expanding the fund’s presence to Asia Pacific. Prior to joining Novartis she was an Associate Partner at McKinsey and Company, a global consultancy, where she worked with companies in health care in the US, Europe and Emerging Markets. Anja König is a scientist by training and holds a PhD in physics from Cornell University. Anja serves on the boards of Bicycle, Covagen, Heptares, F2G and Nabriva and works with Destiny, Neomics, Oxagen, PharmAbcine, Polyphor and Qurient Therapeutics.
Position in the VCSift Database
- • 7 investors at Novartis Venture Fund are tracked.
- • 1 investors hold the Global Head Novartis Venture Fund role in VCSift. Anja König is one of them.
- • 121 investors are based in Basel, Basel-Stadt, Switzerland.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Basel, Switzerland
Contact Information
linkedin.com/in/••••••••
Find more investors like Anja
Search Investors